Press Release: Seton Hall University School of Law Launches European Healthcare Compliance Certification Programme in Paris

Co-presented by:
Seton Hall School of Law and Sciences Po


PRESS RELEASE
 Phone: 973.642-8863
E-mail: simone.handler-hutchinson@shu.edu
Website: law.shu.edu/Paris OR www.sciences-po.fr/spf/healthcare

WASHINGTON DC USA -- HEALTHCARE UPDATE NEWS SERVICE™ -- MAY 19, 2010: The Healthcare Compliance Certification Programme, co-organized by Sciences Po Executive Education (Paris, France) and Seton Hall University School of Law (Newark, N.J) to be held from June 21-25, 2010 on the Paris campus of Sciences Po today announced its 2010 topics and faculty.

FEATURED FACULTY:

CURRENT & FORMER REGULATORY & ENFORCEMENT OFFICIALS:
Paul McNulty, Partner, Baker & McKenzie, LLP (DC) Former U.S. Deputy Attorney General
Kirk Ogrosky, Partner, Arnold & Porter LLP (DC), Former Deputy Chief, Health Care Fraud, Criminal Division, U.S. Dept. of Justice

INTERNATIONAL ORGANIZATIONS
Alex Conte, Senior Legal Analyst, Anti-Corruption Division, OECD
Dr. Guitelle Baghdadi-Sabeti, Team Leader, Good Governance for Medicines, World Health Organization
Marie-Claire Pickaert, Deputy Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)

COMPANY COMPLIANCE PROFESSIONALS:
Dirk Brinckman, Assistant General Counsel, Johnson & Johnson (Brussels)
Roeland Van Aelst, Vice President, EMEA & Canada, Office of Health Care Compliance & Privacy, Johnson & Johnson

KEYNOTE & ACADEMIC SPEAKERS:
Paul Benkimoun, Healthcare Journalist, Le Monde
Claude Le Pen, Professor, Université Paris-Dauphine
Kathleen Boozang, Professor of Law, Seton Hall Law School (Newark, NJ)

LEADING LEGAL AND COMPLIANCE COUNSEL AND ADVISORS:
Peter W.L. Bogaert, Managing Partner, Covington & Burling (Brussels)
John Rupp, Partner, Covington & Burling LLP (London)
Karolos Seeger, Partner, Debevoise & Plimpton LLP (London)
Susie Smith, Bevan Brittan LLP (UK)
Ted Acosta, Leader, Life Sciences & Corporate Compliance Fraud Investigation & Dispute Services, Ernst & Young LLP
Jill Deal, Partner, Venable LLP (DC)
Kristof Van Quathem, Data Protection Advisor, Covington & Burling LLP (Brussels)
Carolyn Lindsey, Director of Member Services, TRACE International
Owen Bevan, Director, Legal & Compliance Practice, Corporate Executive Board

PROGRAMME CURRICULUM:

  • OECD Convention & Other Anti-corruption StandardS
  • UK Bribery Act: Current Perspective & History
  • To Europe and Beyond: the Impact of the U.S. Foreign Corrupt Practices Act
  • EU Competition Law in Healthcare
  • Approval Processes for New Drugs & Devices
  • Harmonization Efforts by the European Medicines Agency & U.S. Food & Drug AdministratioN
  • A Sampling of Healthcare Reimbursement & Delivery Programs Around the World
  • Current Transnational Landscape for Enforcement by Authorities
  • Lessons Learned from U.S. Healthcare Fraud & Abuse Enforcement and Compliance Programs
  • Scientific & Educational Activities • Managing Risk: Third Party Relationships
  • Global Anti-Corruption Issues and Efforts: A View from Trace International
  • Organizational & Operational Keys to Effective Compliance Program Organization
  • Beyond Sales & Marketing: Interactions with Government Officials Throughout the Product Life-cycle
  • Advertising and Promotion of Drugs, Devices and OTC products
  • Public Procurement Processes for Healthcare Products & Services
  • Role of Drug & Device Industry Codes
  • Privacy & Data Protection Laws as Related to Anti-corruption Compliance
  • Assessing and Demonstrating Compliance Program Effectiveness